🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

GNRI and PNI for Predicting Short-Term Outcomes in Older Adults With Multiple Rib Fractures

Recruitingn/aAges 65 Years - anyAllAnkara Etlik City Hospital
NCT07823712 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective observational cohort study will evaluate whether the Geriatric Nutritional Risk Index (GNRI) and Prognostic Nutritional Index (PNI) can predict short-term clinical outcomes in adults aged 65 years or older with isolated blunt thoracic trauma and more than three rib fractures. Participants will be enrolled in the Emergency Department of Ankara Etlik City Hospital. No experimental drug, device, or additional invasive procedure will be used. Routine clinical, laboratory, anthropometric, imaging, and follow-up data will be recorded. The study plans to include 294 participants. The primary outcome is a composite short-term poor clinical outcome, including in-hospital mortality, intensive care unit admission, invasive or non-invasive mechanical ventilation, pneumonia, atelectasis, tube thoracostomy, or hospital stay of 7 days or longer. The prognostic performances of GNRI and

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age 65 years or older. 2. Presentation to the emergency department with blunt thoracic trauma. 3. More than three rib fractures confirmed by thoracic computed tomography or another appropriate radiologic method. 4. Isolated thoracic trauma without major extra-thoracic injury. 5. Serum albumin level, total lymphocyte count, height, and weight available within the first 24 hours after presentation. 6. Written informed consent obtained from the patient or the legally authorized representative. Exclusion Criteria: 1. Penetrating thoracic trauma. 2. Single rib fracture. 3. Intubation at presentation. 4. Polytrauma or major extra-thoracic injury. 5. Known advanced liver failure, nephrotic syndrome, end-stage renal disease, or hematologic disease that may substantially affect albumin or lymphocyte levels. 6. Active malignancy or cachexia related to advanced malignancy. 7. Missing data. 8. Refusal to participate in the study.
💊

What it tests

  • Not listed
📍

Where

1 site
Ankara Etlik City Hospital, Department of Emergency Medicine
Ankara, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy